-
Research involving crayfish spotlights the issue of medications entering the environment through improper disposal or excreting amounts in the bathroom.
-
When a new drug is up for FDA approval, trials may be held not only in the U.S. but other countries too. A study looks at global availability after approval. Big Pharma disagrees with the findings.
-
More than 200,000 doses of COVID vaccine have gone to waste since December, KHN has learned. Two national pharmacy chains account for most of it.
-
On Thursday, Gov. Ron DeSantis included $15 million in his proposed 2021-22 budget for an importation program. That would come on top of $10 million the Legislature already directed toward the plan.
-
The pandemic was the dominant — but not the only — health policy story of 2020. In this Kaiser Health News podcast, panelists look at some of the year's biggest non-coronavirus stories.
-
The controversial deal hashed out between the Department of Justice and the maker of Oxycontin provides hundreds of millions of dollars of relief for communities hit hard by the opioid epidemic.
-
Florida’s plan to import cheaper prescription drugs from Canada — designed by Gov. Ron DeSantis and endorsed by President Donald Trump — has tasted its…
-
Critics say the settlement doesn't hold company executives or members of the Sackler family accountable for their aggressive marketing of OxyContin, which helped fuel the nation's opioid epidemic.
-
Don’t worry. Future COVID-19 vaccinations will be affordable and available. That was the message that Lori M. Reilly, chief operating officer of the…
-
California will be the first state to create its own line of generic drugs to cope with high drug prices. A new law lets the state outsource manufacturing but control pricing and distribution.